Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Alimta Market Growth 2022-2028

  • LP 4756870
  • 79 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Alimta will have significant change from previous year. According to our (LP Information) latest study, the global Alimta market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Alimta market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Alimta market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Alimta market, reaching US$ million by the year 2028. As for the Europe Alimta landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Alimta players cover Eli Lilly, Abbott Healthcare, Cadila Healthcare, and Eagle Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Alimta market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

100mg

500mg

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Pleural Mesothelioma

Non-small Cell Lung Cancer

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Eli Lilly

Abbott Healthcare

Cadila Healthcare

Eagle Pharmaceuticals

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Alimta Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Alimta by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Alimta by Country/Region, 2017, 2022 & 2028

2.2 Alimta Segment by Type

2.2.1 100mg

2.2.2 500mg

2.3 Alimta Sales by Type

2.3.1 Global Alimta Sales Market Share by Type (2017-2022)

2.3.2 Global Alimta Revenue and Market Share by Type (2017-2022)

2.3.3 Global Alimta Sale Price by Type (2017-2022)

2.4 Alimta Segment by Application

2.4.1 Pleural Mesothelioma

2.4.2 Non-small Cell Lung Cancer

2.5 Alimta Sales by Application

2.5.1 Global Alimta Sale Market Share by Application (2017-2022)

2.5.2 Global Alimta Revenue and Market Share by Application (2017-2022)

2.5.3 Global Alimta Sale Price by Application (2017-2022)

3 Global Alimta by Company

3.1 Global Alimta Breakdown Data by Company

3.1.1 Global Alimta Annual Sales by Company (2020-2022)

3.1.2 Global Alimta Sales Market Share by Company (2020-2022)

3.2 Global Alimta Annual Revenue by Company (2020-2022)

3.2.1 Global Alimta Revenue by Company (2020-2022)

3.2.2 Global Alimta Revenue Market Share by Company (2020-2022)

3.3 Global Alimta Sale Price by Company

3.4 Key Manufacturers Alimta Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Alimta Product Location Distribution

3.4.2 Players Alimta Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Alimta by Geographic Region

4.1 World Historic Alimta Market Size by Geographic Region (2017-2022)

4.1.1 Global Alimta Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Alimta Annual Revenue by Geographic Region

4.2 World Historic Alimta Market Size by Country/Region (2017-2022)

4.2.1 Global Alimta Annual Sales by Country/Region (2017-2022)

4.2.2 Global Alimta Annual Revenue by Country/Region

4.3 Americas Alimta Sales Growth

4.4 APAC Alimta Sales Growth

4.5 Europe Alimta Sales Growth

4.6 Middle East & Africa Alimta Sales Growth

5 Americas

5.1 Americas Alimta Sales by Country

5.1.1 Americas Alimta Sales by Country (2017-2022)

5.1.2 Americas Alimta Revenue by Country (2017-2022)

5.2 Americas Alimta Sales by Type

5.3 Americas Alimta Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Alimta Sales by Region

6.1.1 APAC Alimta Sales by Region (2017-2022)

6.1.2 APAC Alimta Revenue by Region (2017-2022)

6.2 APAC Alimta Sales by Type

6.3 APAC Alimta Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Alimta by Country

7.1.1 Europe Alimta Sales by Country (2017-2022)

7.1.2 Europe Alimta Revenue by Country (2017-2022)

7.2 Europe Alimta Sales by Type

7.3 Europe Alimta Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Alimta by Country

8.1.1 Middle East & Africa Alimta Sales by Country (2017-2022)

8.1.2 Middle East & Africa Alimta Revenue by Country (2017-2022)

8.2 Middle East & Africa Alimta Sales by Type

8.3 Middle East & Africa Alimta Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Alimta

10.3 Manufacturing Process Analysis of Alimta

10.4 Industry Chain Structure of Alimta

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Alimta Distributors

11.3 Alimta Customer

12 World Forecast Review for Alimta by Geographic Region

12.1 Global Alimta Market Size Forecast by Region

12.1.1 Global Alimta Forecast by Region (2023-2028)

12.1.2 Global Alimta Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Alimta Forecast by Type

12.7 Global Alimta Forecast by Application

13 Key Players Analysis

13.1 Eli Lilly

13.1.1 Eli Lilly Company Information

13.1.2 Eli Lilly Alimta Product Offered

13.1.3 Eli Lilly Alimta Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Eli Lilly Main Business Overview

13.1.5 Eli Lilly Latest Developments

13.2 Abbott Healthcare

13.2.1 Abbott Healthcare Company Information

13.2.2 Abbott Healthcare Alimta Product Offered

13.2.3 Abbott Healthcare Alimta Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Abbott Healthcare Main Business Overview

13.2.5 Abbott Healthcare Latest Developments

13.3 Cadila Healthcare

13.3.1 Cadila Healthcare Company Information

13.3.2 Cadila Healthcare Alimta Product Offered

13.3.3 Cadila Healthcare Alimta Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Cadila Healthcare Main Business Overview

13.3.5 Cadila Healthcare Latest Developments

13.4 Eagle Pharmaceuticals

13.4.1 Eagle Pharmaceuticals Company Information

13.4.2 Eagle Pharmaceuticals Alimta Product Offered

13.4.3 Eagle Pharmaceuticals Alimta Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Eagle Pharmaceuticals Main Business Overview

13.4.5 Eagle Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Alimta Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Alimta Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 100mg

Table 4. Major Players of 500mg

Table 5. Global Alimta Sales by Type (2017-2022) & (Kg)

Table 6. Global Alimta Sales Market Share by Type (2017-2022)

Table 7. Global Alimta Revenue by Type (2017-2022) & ($ million)

Table 8. Global Alimta Revenue Market Share by Type (2017-2022)

Table 9. Global Alimta Sale Price by Type (2017-2022) & (USD/g)

Table 10. Global Alimta Sales by Application (2017-2022) & (Kg)

Table 11. Global Alimta Sales Market Share by Application (2017-2022)

Table 12. Global Alimta Revenue by Application (2017-2022)

Table 13. Global Alimta Revenue Market Share by Application (2017-2022)

Table 14. Global Alimta Sale Price by Application (2017-2022) & (USD/g)

Table 15. Global Alimta Sales by Company (2020-2022) & (Kg)

Table 16. Global Alimta Sales Market Share by Company (2020-2022)

Table 17. Global Alimta Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Alimta Revenue Market Share by Company (2020-2022)

Table 19. Global Alimta Sale Price by Company (2020-2022) & (USD/g)

Table 20. Key Manufacturers Alimta Producing Area Distribution and Sales Area

Table 21. Players Alimta Products Offered

Table 22. Alimta Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Alimta Sales by Geographic Region (2017-2022) & (Kg)

Table 26. Global Alimta Sales Market Share Geographic Region (2017-2022)

Table 27. Global Alimta Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Alimta Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Alimta Sales by Country/Region (2017-2022) & (Kg)

Table 30. Global Alimta Sales Market Share by Country/Region (2017-2022)

Table 31. Global Alimta Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Alimta Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Alimta Sales by Country (2017-2022) & (Kg)

Table 34. Americas Alimta Sales Market Share by Country (2017-2022)

Table 35. Americas Alimta Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Alimta Revenue Market Share by Country (2017-2022)

Table 37. Americas Alimta Sales by Type (2017-2022) & (Kg)

Table 38. Americas Alimta Sales Market Share by Type (2017-2022)

Table 39. Americas Alimta Sales by Application (2017-2022) & (Kg)

Table 40. Americas Alimta Sales Market Share by Application (2017-2022)

Table 41. APAC Alimta Sales by Region (2017-2022) & (Kg)

Table 42. APAC Alimta Sales Market Share by Region (2017-2022)

Table 43. APAC Alimta Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Alimta Revenue Market Share by Region (2017-2022)

Table 45. APAC Alimta Sales by Type (2017-2022) & (Kg)

Table 46. APAC Alimta Sales Market Share by Type (2017-2022)

Table 47. APAC Alimta Sales by Application (2017-2022) & (Kg)

Table 48. APAC Alimta Sales Market Share by Application (2017-2022)

Table 49. Europe Alimta Sales by Country (2017-2022) & (Kg)

Table 50. Europe Alimta Sales Market Share by Country (2017-2022)

Table 51. Europe Alimta Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Alimta Revenue Market Share by Country (2017-2022)

Table 53. Europe Alimta Sales by Type (2017-2022) & (Kg)

Table 54. Europe Alimta Sales Market Share by Type (2017-2022)

Table 55. Europe Alimta Sales by Application (2017-2022) & (Kg)

Table 56. Europe Alimta Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Alimta Sales by Country (2017-2022) & (Kg)

Table 58. Middle East & Africa Alimta Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Alimta Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Alimta Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Alimta Sales by Type (2017-2022) & (Kg)

Table 62. Middle East & Africa Alimta Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Alimta Sales by Application (2017-2022) & (Kg)

Table 64. Middle East & Africa Alimta Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Alimta

Table 66. Key Market Challenges & Risks of Alimta

Table 67. Key Industry Trends of Alimta

Table 68. Alimta Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Alimta Distributors List

Table 71. Alimta Customer List

Table 72. Global Alimta Sales Forecast by Region (2023-2028) & (Kg)

Table 73. Global Alimta Sales Market Forecast by Region

Table 74. Global Alimta Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Alimta Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Alimta Sales Forecast by Country (2023-2028) & (Kg)

Table 77. Americas Alimta Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Alimta Sales Forecast by Region (2023-2028) & (Kg)

Table 79. APAC Alimta Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Alimta Sales Forecast by Country (2023-2028) & (Kg)

Table 81. Europe Alimta Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Alimta Sales Forecast by Country (2023-2028) & (Kg)

Table 83. Middle East & Africa Alimta Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Alimta Sales Forecast by Type (2023-2028) & (Kg)

Table 85. Global Alimta Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Alimta Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Alimta Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Alimta Sales Forecast by Application (2023-2028) & (Kg)

Table 89. Global Alimta Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Alimta Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Alimta Revenue Market Share Forecast by Application (2023-2028)

Table 92. Eli Lilly Basic Information, Alimta Manufacturing Base, Sales Area and Its Competitors

Table 93. Eli Lilly Alimta Product Offered

Table 94. Eli Lilly Alimta Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 95. Eli Lilly Main Business

Table 96. Eli Lilly Latest Developments

Table 97. Abbott Healthcare Basic Information, Alimta Manufacturing Base, Sales Area and Its Competitors

Table 98. Abbott Healthcare Alimta Product Offered

Table 99. Abbott Healthcare Alimta Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 100. Abbott Healthcare Main Business

Table 101. Abbott Healthcare Latest Developments

Table 102. Cadila Healthcare Basic Information, Alimta Manufacturing Base, Sales Area and Its Competitors

Table 103. Cadila Healthcare Alimta Product Offered

Table 104. Cadila Healthcare Alimta Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 105. Cadila Healthcare Main Business

Table 106. Cadila Healthcare Latest Developments

Table 107. Eagle Pharmaceuticals Basic Information, Alimta Manufacturing Base, Sales Area and Its Competitors

Table 108. Eagle Pharmaceuticals Alimta Product Offered

Table 109. Eagle Pharmaceuticals Alimta Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 110. Eagle Pharmaceuticals Main Business

Table 111. Eagle Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Alimta

Figure 2. Alimta Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Alimta Sales Growth Rate 2017-2028 (Kg)

Figure 7. Global Alimta Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Alimta Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 100mg

Figure 10. Product Picture of 500mg

Figure 11. Global Alimta Sales Market Share by Type in 2021

Figure 12. Global Alimta Revenue Market Share by Type (2017-2022)

Figure 13. Alimta Consumed in Pleural Mesothelioma

Figure 14. Global Alimta Market: Pleural Mesothelioma (2017-2022) & (Kg)

Figure 15. Alimta Consumed in Non-small Cell Lung Cancer

Figure 16. Global Alimta Market: Non-small Cell Lung Cancer (2017-2022) & (Kg)

Figure 17. Global Alimta Sales Market Share by Application (2017-2022)

Figure 18. Global Alimta Revenue Market Share by Application in 2021

Figure 19. Alimta Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Alimta Revenue Market Share by Company in 2021

Figure 21. Global Alimta Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Alimta Revenue Market Share by Geographic Region in 2021

Figure 23. Global Alimta Sales Market Share by Region (2017-2022)

Figure 24. Global Alimta Revenue Market Share by Country/Region in 2021

Figure 25. Americas Alimta Sales 2017-2022 (Kg)

Figure 26. Americas Alimta Revenue 2017-2022 ($ Millions)

Figure 27. APAC Alimta Sales 2017-2022 (Kg)

Figure 28. APAC Alimta Revenue 2017-2022 ($ Millions)

Figure 29. Europe Alimta Sales 2017-2022 (Kg)

Figure 30. Europe Alimta Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Alimta Sales 2017-2022 (Kg)

Figure 32. Middle East & Africa Alimta Revenue 2017-2022 ($ Millions)

Figure 33. Americas Alimta Sales Market Share by Country in 2021

Figure 34. Americas Alimta Revenue Market Share by Country in 2021

Figure 35. United States Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Alimta Sales Market Share by Region in 2021

Figure 40. APAC Alimta Revenue Market Share by Regions in 2021

Figure 41. China Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Alimta Sales Market Share by Country in 2021

Figure 48. Europe Alimta Revenue Market Share by Country in 2021

Figure 49. Germany Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Alimta Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Alimta Revenue Market Share by Country in 2021

Figure 56. Egypt Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Alimta Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Alimta in 2021

Figure 62. Manufacturing Process Analysis of Alimta

Figure 63. Industry Chain Structure of Alimta

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390